Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles

José M. Espejo-Román; Belén Rubio-Ruiz; Victoria Cano-Cortés; Olga Cruz-López; Saúl Gonzalez-Resines; Carmen Domene; Ana Conejo-García; Rosario M. Sánchez-Martín

doi:10.3390/pharmaceutics14040788

Pharmaceutics (Apr 2022)

Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles

José M. Espejo-Román,
Belén Rubio-Ruiz,
Victoria Cano-Cortés,
Olga Cruz-López,
Saúl Gonzalez-Resines,
Carmen Domene,
Ana Conejo-García,
Rosario M. Sánchez-Martín

Affiliations

José M. Espejo-Román: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain
Belén Rubio-Ruiz: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain
Victoria Cano-Cortés: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain
Olga Cruz-López: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain
Saúl Gonzalez-Resines: Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AX, UK
Carmen Domene: Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AX, UK
Ana Conejo-García: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain
Rosario M. Sánchez-Martín: Department of Medicinal and Organic Chemistry and Excellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Faculty of Pharmacy, Campus Cartuja s/n, University of Granada, 18071 Granada, Spain

DOI: https://doi.org/10.3390/pharmaceutics14040788
Journal volume & issue: Vol. 14, no. 4
p. 788

Abstract

Read online

Hyaluronic acid (HA), through its interactions with the cluster of differentiation 44 (CD44), acts as a potent modulator of the tumor microenvironment, creating a wide range of extracellular stimuli for tumor growth, angiogenesis, invasion, and metastasis. An innovative antitumor treatment strategy based on the development of a nanodevice for selective release of an inhibitor of the HA-CD44 interaction is presented. Computational analysis was performed to evaluate the interaction of the designed tetrahydroisoquinoline-ketone derivative (JE22) with CD44 binding site. Cell viability, efficiency, and selectivity of drug release under acidic conditions together with CD44 binding capacity, effect on cell migration, and apoptotic activity were successfully evaluated. Remarkably, the conjugation of this CD44 inhibitor to the nanodevice generated a reduction of the dosis required to achieve a significant therapeutic effect.

Published in Pharmaceutics

ISSN: 1999-4923 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pharmacy and materia medica
Website: http://www.mdpi.com/journal/pharmaceutics/

About the journal

Abstract

Keywords